Early Exposure to OMT Prevents Long LOS
Not Applicable
Completed
- Conditions
- Prematurity
- Interventions
- Other: osteopathic manipulative treatmentOther: Usual care
- Registration Number
- NCT01784835
- Lead Sponsor
- European Institute for Evidence Based Osteopathic Medicine
- Brief Summary
The application of osteopathic manipulative treatment (OMT) in preterm infants has been demonstrated to be effective in reducing length of stay (LOS). The scope of the present study is to investigate the association between earlier exposure to OMT and reduction of LOS in premature infants
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 113
Inclusion Criteria
- preterm infants born at age between 29 and 37 weeks
- osteopathic treatment performed < 14 days after birth
- preterms born in the same hospital
Exclusion Criteria
- Gestational age < 29 weeks
- Gestational age > 37 weeks
- First OMT performed after 14 days from birth
- genetic disorders
- congenital disorders
- cardiovascular abnormalities
- proven or suspected necrotized enterocolitis with or without gastrointestinal perforation proven or suspected abdominal obstruction
- pre/post surgery patients
- pneumoperitoneum
- atelectasis
- Newborn from an HIV seropositive/drug addicted mother
- respiratory disorders
- transferred to/from other hospital
- admitted for preterminal comfort care (defined as neither intubation nor cardio-respiratory resuscitation)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description OMT osteopathic manipulative treatment patients under usual medical care plus osteopathic treatment control Usual care patients under standard medical care
- Primary Outcome Measures
Name Time Method Number of days of LOS participants will be followed for the duration of hospital stay, an expected average of 4 weeks
- Secondary Outcome Measures
Name Time Method effectiveness of OMT considering different lag time between birth and the first OMT participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Trial Locations
- Locations (1)
Macerata Hospital
🇮🇹Macerata, Italy